The role of clinical pharmacists in chronic disease management: Review
Keywords:
Chronic disease management, Clinical pharmacists, Inflammatory bowel disease, Medication adherence, Multidisciplinary careAbstract
Background: Chronic diseases, particularly non-communicable diseases (NCDs), are leading causes of morbidity and mortality globally. Effective management of these conditions, such as inflammatory bowel disease (IBD), requires a multidisciplinary approach, including the integration of clinical pharmacists into patient care teams. Methods: This review analyzed literature from seven databases, including MEDLINE and EMBASE, focusing on pharmacist interventions in the management of chronic diseases, specifically type 2 diabetes and asthma, to assess their applicability to IBD. Studies published between 2014 and 2023 were included to evaluate the impact of pharmacist-led initiatives on clinical outcomes. Results: The findings reveal that pharmacist interventions significantly improve patient outcomes in chronic disease management through medication management, patient education, and regular monitoring. While type 2 diabetes and asthma management strategies have been well-documented, there is a notable gap in research regarding pharmacist involvement in IBD care. Proposed interventions for IBD include medication adherence support, risk assessment, and preventive health services, which have demonstrated effectiveness in other chronic conditions. Conclusion: The integration of clinical pharmacists into the management of inflammatory bowel disease presents a valuable opportunity to enhance patient care.
Downloads
References
Pinto GS, Bader L, Billberg K, Criddle D, Duggan C, El Bizri L, Gharat M, Hogue MD, Jacinto I, Oyeneyin Y, Zhou Y. Beating non-communicable diseases in primary health care: the contribution of pharmacists and guidance from FIP to support WHO goals. Research in Social and Administrative Pharmacy. 2020 Jul 1;16(7):974-7. DOI: https://doi.org/10.1016/j.sapharm.2019.10.008
World Health Organization (WHO). Preventing Chronic Disease: A Vital Investiment. WHO Global Report. Available online: http://who.int/chp/chronic_disease_report/en.
Freeman T, Baum F, Javanparast S, Ziersch A, Mackean T, Windle A. Challenges facing primary health care in federated government systems: implementation of primary health networks in Australian states and territories. Health Policy. 2021 Apr 1;125(4):495-503. DOI: https://doi.org/10.1016/j.healthpol.2021.02.002
De Maeseneer J, Li D, Palsdottir B, Mash B, Aarendonk D, Stavdal A, Moosa S, Decat P, Kiguli-Malwadde E, Ooms G, Willems S. Universal health coverage and primary health care: the 30 by 2030 campaign. Bulletin of the World Health Organization. 2020 Nov 11;98(11):812. DOI: https://doi.org/10.2471/BLT.19.245670
Sun Q, Tang Y, Dai L, Tang Z, Zhou W, Wu T, Ji G. Serum bile acid metabolites predict the therapeutic effect of Mesalazine in patients with ulcerative colitis. Journal of Proteome Research. 2023 Mar 15;22(4):1287-97. DOI: https://doi.org/10.1021/acs.jproteome.2c00820
Schurman JV, Friesen CA. Leveraging institutional support to build an integrated multidisciplinary care model in pediatric inflammatory bowel disease. Children. 2021 Apr 8;8(4):286. DOI: https://doi.org/10.3390/children8040286
Ahmad OF, Ayubi H, Clough J, Dart R, Gadhok R, Pannick S, Parkes G, Pavlidis P, Segal J, Sellers P. Quality of care in adult patients with inflammatory bowel disease transferring between healthcare providers: multicentre audit. Frontline Gastroenterology. 2021 Jan 1;12(1):5-10. DOI: https://doi.org/10.1136/flgastro-2019-101347
Prasad, S.S.; Potter, M.; Keely, S.; Talley, N.J.; Walker, M.M.; Kairuz, T. Roles of healthcare professionals in the management of chronic gastrointestinal diseases with a focus on primary care: A systematic review. JGH Open 2020, 4, 221–229. DOI: https://doi.org/10.1002/jgh3.12235
Prasad SS, Duncanson K, Keely S, Talley NJ, Kairuz T, Holtmann GJ, Shah A, Walker MM. A role for primary care pharmacists in the management of inflammatory bowel disease? Lessons from chronic disease: a systematic review. Pharmacy. 2020 Nov 2;8(4):204. DOI: https://doi.org/10.3390/pharmacy8040204
Hughes, C.A.; Breault, R.R.; Hicks, D.; Schindel, T.J. Positioning pharmacists’ roles in primary health care: A discourse analysis of the compensation plan in Alberta, Canada. BMC Health Serv. Res. 2017, 17, 770. DOI: https://doi.org/10.1186/s12913-017-2734-x
Houle, S.K.; Grindrod, K.A.; Chatterley, T.; Tsuyuki, R.T. Paying pharmacists for patient care: A systematic review of remunerated pharmacy clinical care services. Can. Pharm. J. 2014, 147, 209–232. DOI: https://doi.org/10.1177/1715163514536678
Koltun, W.A. Better together: Improved care of the IBD patient using the multi-disciplinary IBD center. Expert Rev. Gastroenterol. Hepatol. 2017, 11, 491–493. DOI: https://doi.org/10.1080/17474124.2017.1309289
Lee, C.K.; Melmed, G.Y. Multidisciplinary Team-Based Approaches to IBD Management: How Might “One-Stop Shopping” Work for Complex IBD Care? Am. J. Gastroenterol. 2017, 112, 825–827. DOI: https://doi.org/10.1038/ajg.2017.124
Fiorino, G.; Allocca, M.; Chaparro, M.; Coenen, S.; Fidalgo, C.; Younge, L.; Gisbert, J.P. ‘Quality of Care’ Standards in Inflammatory Bowel Disease: A Systematic Review. J. Crohns Colitis 2019, 13, 127–137. DOI: https://doi.org/10.1093/ecco-jcc/jjy140
Farraye, F.A.; Melmed, G.Y.; Lichtenstein, G.R.; Kane, S.V. ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease. Am. J. Gastroenterol. 2017, 112, 241–258. DOI: https://doi.org/10.1038/ajg.2016.537
Torres, J.; Burisch, J.; Riddle, M.; Dubinsky, M.; Colombel, J.F. Preclinical disease and preventive strategies in IBD: Perspectives, challenges and opportunities. Gut 2016, 65, 1061–1069. DOI: https://doi.org/10.1136/gutjnl-2016-311785
Yeshi K, Ruscher R, Hunter L, Daly NL, Loukas A, Wangchuk P. Revisiting inflammatory bowel disease: pathology, treatments, challenges and emerging therapeutics including drug leads from natural products. Journal of Clinical Medicine. 2020 Apr 28;9(5):1273. DOI: https://doi.org/10.3390/jcm9051273
Le LM, Veettil SK, Donaldson D, Kategeaw W, Hutubessy R, Lambach P, Chaiyakunapruk N. The impact of pharmacist involvement on immunization uptake and other outcomes: An updated systematic review and meta-analysis. Journal of the American Pharmacists Association. 2022 Sep 1;62(5):1499-513. DOI: https://doi.org/10.1016/j.japh.2022.06.008
Krishnan A, Mathur P, Kulothungan V, Salve HR, Leburu S, Amarchand R, Nongkynrih B, Chaturvedi HK, Ganeshkumar P, KS VU, Laxmaiah A. Preparedness of primary and secondary health facilities in India to address major non-communicable diseases: results of a National Noncommunicable Disease Monitoring Survey (NNMS). BMC Health Services Research. 2021 Dec;21:1-2. DOI: https://doi.org/10.1186/s12913-021-06530-0
Deng ZJ, Gui L, Chen J, Peng SS, Ding YF, Wei AH. Clinical, economic and humanistic outcomes of medication therapy management services: A systematic review and meta-analysis. Frontiers in Pharmacology. 2023 Apr 5;14:1143444. DOI: https://doi.org/10.3389/fphar.2023.1143444
Pousinho S, Morgado M, Plácido AI, Roque F, Falcão A, Alves G. Clinical pharmacists interventions in the management of type 2 diabetes mellitus: a systematic review. Pharmacy Practice (Granada). 2020 Sep;18(3). DOI: https://doi.org/10.18549/PharmPract.2020.3.2000
Chow, E.P.; Hassali, M.A.; Saleem, F.; Aljadhey, H. Effects of pharmacist-led patient education on diabetes-related knowledge and medication adherence: A home-based study. Health Educ. J. 2015, 75, 421–433. DOI: https://doi.org/10.1177/0017896915597021
Hendrie, D.; Miller, T.R.; Woodman, R.J.; Hoti, K.; Hughes, J. Cost-effectiveness of reducing glycaemic episodes through community pharmacy management of patients with type 2 diabetes mellitus. J. Prim. Prev. 2014, 35, 439–449. DOI: https://doi.org/10.1007/s10935-014-0368-x
Frederick A, Juan J, Ivy D, Maldonado YM. Effect of visit frequency of pharmacist-led diabetes medication management program. Journal of Pharmacy Practice. 2022 Feb;35(1):70-4. DOI: https://doi.org/10.1177/0897190020948685
Shawahna R, Thawabi F, Salah R, Ramadan S. Pharmaceutical care services for patients with diabetes: a systematic scoping review. American Journal of Managed Care. 2022 Sep 1;28(9). DOI: https://doi.org/10.37765/ajmc.2022.89227
Prasad SS. Exploring the role of pharmacists in the primary care management of Inflammatory Bowel Disease. 2021.
Serhal S, Saini B, Bosnic-Anticevich S, Krass I, Emmerton L, Bereznicki B, Bereznicki L, Mitchell B, Wilson F, Wright B, Wilson K. A targeted approach to improve asthma control using community pharmacists. Frontiers in Pharmacology. 2021 Dec 27;12:798263. DOI: https://doi.org/10.3389/fphar.2021.798263
Cui L, Huang Y, Yao D, Zhu H, Li W, Yao W. Impact of antibiotic therapy management by clinical pharmacists on rational drug use in the perioperative period of retinal detachment surgery in China: a retrospective study from the perspective of prescription structure. Food Science and Technology. 2021 Jul 9;42:e34921. DOI: https://doi.org/10.1590/fst.34921
Turcotte C, Fénélon-Dimanche R, Lemière C, Beauchesne MF, Abou-Atmé B, Chabot I, Blais L. Development of a community pharmacy-based intervention for patients with uncontrolled asthma. Exploratory Research in Clinical and Social Pharmacy. 2022 Sep 1;7:100167. DOI: https://doi.org/10.1016/j.rcsop.2022.100167
Zairina E, Nugraheni G, Achmad GN, Sulistyarini A, Nita Y, Faisal S, Bakhtiar A, Amin M. Efficacy of an education session by pharmacists for patients with asthma: A randomised controlled trial. Pharmacy Education. 2021;22(1):980-8. DOI: https://doi.org/10.46542/pe.2022.221.980988
Aje AA, Aina OA. An intervention study of pharmacists’ knowledge and patient counseling on metered dose inhalers and nebulizers. African Journal of Biomedical Research. 2020 Sep 30;23(3):313-9.
Abegunde, A.T.; Muhammad, B.H.; Ali, T. Preventive health measures in inflammatory bowel disease. World J. Gastroenterol. 2016, 22, 7625–7644. DOI: https://doi.org/10.3748/wjg.v22.i34.7625
Paterick, T.E.; Patel, N.; Tajik, A.J.; Chandrasekaran, K. Improving health outcomes through patient education and partnerships with patients. Proceedings (Bayl. Univ. Med. Cent.) 2017, 30, 112–113. DOI: https://doi.org/10.1080/08998280.2017.11929552
McDermott, E.; Healy, G.; Mullen, G.; Keegan, D.; Byrne, K.; Guerandel, A.; Forry, M.; Moloney, J.; Doherty, G.; Cullen, G.; et al. Patient Education in Inflammatory Bowel Disease: A Patient-Centred, Mixed Methodology Study. J. Crohns Colitis 2018, 12, 419–424. DOI: https://doi.org/10.1093/ecco-jcc/jjx175
Chan, W.; Chen, A.; Tiao, D.; Selinger, C.; Leong, R. Medication adherence in inflammatory bowel disease. Intest. Res. 2017, 15, 434–445. DOI: https://doi.org/10.5217/ir.2017.15.4.434
Tiao, D.K.; Chan, W.; Jeganathan, J.; Chan, J.T.; Perry, J.; Selinger, C.P.; Leong, R.W. Inflammatory Bowel Disease Pharmacist Adherence Counseling Improves Medication Adherence in Crohn’s Disease and Ulcerative Colitis. Inflamm. Bowel. Dis. 2017, 23, 1257–1261. DOI: https://doi.org/10.1097/MIB.0000000000001194
Burr, N.E.; Smith, C.; West, R.; Hull, M.A.; Subramanian, V. Increasing Prescription of Opiates and Mortality in Patients With Inflammatory Bowel Diseases in England. Clin. Gastroenterol. Hepatol. 2018, 16, 534–541. DOI: https://doi.org/10.1016/j.cgh.2017.10.022
Foy, R.; Leaman, B.; McCrorie, C.; Petty, D.; House, A.; Bennett, M.; Carder, P.; Faulkner, S.; Glidewell, L.; West, R. Prescribed opioids in primary care: Cross-sectional and longitudinal analyses of influence of patient and practice characteristics. BMJ Open 2016, 6, e010276. DOI: https://doi.org/10.1136/bmjopen-2015-010276
Zielinska, A.; Salaga, M.; Wlodarczyk, M.; Fichna, J. Focus on current and future management possibilities in inflammatory bowel disease-related chronic pain. Int. J. Colorectal. Dis. 2019, 34, 217–227. DOI: https://doi.org/10.1007/s00384-018-3218-0
Published
How to Cite
Issue
Section
Copyright (c) 2024 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
